Print
Share
RSS
Donate
AZCERT announces that Sertindole, a drug used in the treatment of schizophrenia, has beem moved from the Possible Risk of Torsades de Pointes (TdP) category to the Known Risk of TdP category because of newly available evidence that it is associated with TdP.
Loading Conversation